Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
Recruiting · NCT06962371 · Registry updated 2025-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, heart valve disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-05-08 | NCT06962371 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascend Clinical | 1 |
| Medical Metrics Diagnostics, Inc | 6 |
| Monash Health | 6 |
| Transverse Medical Australia | 1 |
| Transverse Medical, Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Victorian Heart Hospital | Clayton | Australia | 9 |